Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Writing implement
Powerline communication receiver
Handheld electronic communication device having sliding display
Method of inspecting wafer
Uplink synchronization management in wireless networks
Flexure with insulating layer isolating a portion of a metal substrate
Mobile terminal apparatus, radio base station apparatus and radio communication method
  Randomly Featured Patents
Intake apparatus for internal combustion engine
Method and apparatus for testing integrated circuit devices
Bulk liquid freight transport vehicle
Rotating battery hinge for a notebook computer
Fungicidal carbazates
Method and device for sending and receiving digital images using an image watermark for decoding
Self-locking drill chuck
Retention mechanism for catheter with distal anchor
Martensitic stainless steel composition, method for making a mechanical part from said steel and resulting part
Methods and apparatus for dynamically generating web pages